Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease

Internal Medicine

Volumn 50, Issue 18, 2011, Pages 1973-1976

  Ozlem, Celik ^a   Deram, Buyuktas ^a   Mustafa, Sevinc ^a   Koray, Tascilar ^a   Cuyan, Demirkesen ^a   Ertugrul, Tasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Granulocyte colony stimulating factor; Propylthiouracil; Sweet's syndrome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; IMMUNOGLOBULIN G; MEROPENEM; NEUTROPHIL CYTOPLASMIC ANTIBODY; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; PROPYLTHIOURACIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TECHNETIUM 99M; THYROTROPIN RECEPTOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; AGRANULOCYTOSIS; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DISEASE ASSOCIATION; DRUG SAFETY; DYSPNEA; ERYTHEMA; FATIGUE; FEMALE; FEVER; GRAVES DISEASE; HEMATURIA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MYALGIA; NEUTROPENIA; PANCYTOPENIA; PAPULAR RASH; PHYSICAL EXAMINATION; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; PRURITUS; SKIN BIOPSY; SKIN EDEMA; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTOXICOSIS; TREATMENT RESPONSE; URINALYSIS;

ADULT; AGRANULOCYTOSIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRAVES DISEASE; HUMANS; NEUTROPENIA; PROPYLTHIOURACIL; SKIN; SWEET SYNDROME; THYROID GLAND;

EID: 80052861932     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4483     Document Type: Article

References (15)

1. Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14: 33-41, 2009.
2. Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342: 651-652, 1993.
3. Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil. Int J Clin Pract 63: 299-302, 2009.
4. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 3: 117-131, 2002.
5. Kim MJ, Choe YH. EPONYM: Sweet syndrome. Eur J Pediatr 169: 1439-1444, 2010.
6. Boulenger-Vazel A, Kupfer-Bessaguet I, Gouedard C, et al. Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies). Ann Dermatol Venereol 132: 27-31, 2005.
7. Seo JW, Son HH, Choi JH, Lee SK. A case of p-ANCA-positive propylthiouracil-induced pyoderma gangrenosum. Ann Dermatol 22: 48-50, 2010.
8. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 130: 77-81, 1994.
9. White LE, Villa MT, Petronic-Rosic V, Jiang J, Medenica MM. Pyoderma gangrenosum related to a new granulocyte colonystimulating factor. Skinmed 5: 96-98, 2006.
10. Noh JY, Yasuda S, Sato S, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab 94: 2806-2811, 2009.
11. Miller RM, Darben TA, Nedwich J, Savige J. Propylthiouracilinduced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis. Br J Dermatol 141: 943-944, 1999.
12. Kemmett D, Harrison DJ, Hunter JA. Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol 24: 967-969, 1991.
13. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 3: 117-131, 2002.
14. Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, Müller CA, Waller HD. Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol 84: 356-358, 1993.
15. Otsuka S, Kinebuchi A, Tabata H, Yamakage A, Yamazaki S. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy. Br J Dermatol 142: 828-830, 2000.